AstraZeneca files for US approval of drug to prevent COVID-19

AstraZeneca files for US approval of drug to prevent COVID-19 thumbnail

AstraZeneca files for US approval of drug to prevent COVID-19

Reuters

Synopsis

The treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any COVID-19 symptoms by 77% in a late-stage trial.

AstraZeneca to prevent and cure Covid

said on Tuesday it had submitted a request with U.S. health regulators to grant emergency use authorisation for a new treatment to prevent COVID-19.

The British drugmaker had said in August that the treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any COVID-19 symptoms by 77% in a late-stage trial.

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

ETPrime stories of the day

Leave a comment

Your email address will not be published. Required fields are marked *